Recurrent Apnea in the Newborn

Evidence-Based Pediatrics and Child Health with CD-ROM

Volumn , Issue , 2007, Pages 483-489

  Henderson Smart, David J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bradycardia; Evidence; Lower gestational age; Poor neurological outcome; Recurrent apnea

Indexed keywords

EID: 84955111655     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987384.ch47     Document Type: Chapter

References (35)

1. American Academy of Pediatrics. Policy statement. Apnea, Sudden Infant Death Syndrome, and home monitoring. Pediatrics 2003;111:914-17.
2. Henderson-Smart DJ. The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aus Paed J 1981;17:273-6.
3. Butcher-Puech M, Henderson-Smart DJ, Holley D, Lacey JL and Edwards DA. Relation between apnea duration and type and neurological status of preterm infants. Arch Dis Child 1985;60:634-8.
4. Muttitt SC, Finer NN, Tierney AJ, Rossmann J. Neonatal apnea: diagnosis by nurse versus computer. Pediatrics 1988;82:713-20.
5. Henderson-Smart DJ, Butcher-Puech MC, Edwards DA. Incidence and mechanism of bradycardia during apnoea in preterm infants. Arch Dis Child 1986;61:227-32.
6. Storrs CN. Cardiovascular effects of apnoea in preterm infants. Arch Dis Child 1977;52:534-40.
7. Girling DJ. Changes in heart rate, blood pressure and pulse pressure during apnoeic attacks in newborn babies. Arch Dis Child 1972;47:405-10.
8. Dransfield DA, Spitzer AR, Fox WW. Episodic airway obstruction in premature infants. Am J Dis Child 1983; 137:441-3.
9. Waggener TB, Stark AR, Cohlan BA, Frantz ID III. Apnea duration is related to ventilatory oscillation characteristics in newborn infants. J Appl Physiol 1984;57:536-44.
10. Poets CF, Stebbens VA, Samuels MP, Southall DP. The relationship between bradycardia, apnea and hypoxemia in preterm infants. Pediatr Res 1993;34:144-7.
11. Southall DP, Levitt GA, Richards RM et al. Undetected episodes of prolonged apnea and severe bradycardia in preterm infants. Pediatrics 1983;72:541-51.
12. Lorenz JM, Paneth N. When are observational studies adequate to assess the efficacy of therapeutic interventions. Clin Perinatol 2003;30:269-83.
13. Miller JC, Berle FC, Smull NW. Severe apnea and irregular respiratory rhythms among premature infants. Pediatrics 1959;23:676-85.
14. Tudehope DI, Rogers Y. Clinical spectrum of neonatal apnoea in very low birthweight infants. Austr Paediatr J 1984;20:131-136.
15. Southall DP, Richards JM, Shinebourne EA, Wilson AJ, Alexander JR. Prospective population-based study into heart rate and breathing patterns in newborn infants: prediction of infants at risk of SIDS? In: Tildon JT, Roeder LM, Steinschneider A, eds. Sudden Infant Death Syndrome. New York, Acedemic Press, 1983.
16. Stein IM, Fallon M, Mreisalo RL, Kennedy JL. The frequency of apnea and bradycardia in a population of healthy normal infants. Neuropediatrics 1983;14:73-5.
17. Botham SJ, Isaacs D. Incidence of apnoea and bradycardia in preterm infants following triple antigen immunisation. J Paediatr Child Hlth 1994;30:533-5.
18. Liu LMP, Cote CJ, Goudsouzian NG et al. Life-threatening apnea in infants recovering from anesthesia. Anesthesiology 1983;59:506-10.
19. Colditz PB, Henry RL, Lakshman MD. Apnoea and bronchiolitis due to respiratory syncytial virus. Aust Paed J 1982;18:53-4.
20. Henderson-Smart DJ. Recurrent apnoea. In: Yu VYH, ed. Bailliere's Clinical Paediatrics. Vol 3 No. 1 Pulmonary Problems in the Perinatal Period and their Sequelae. London: Bailliere Tindall, 1995.
21. Barrington K, Finer N. The natural history of apnea of prematurity. Pediatr Res 1991;29:372-5.
22. Henderson-Smart DJ, Pettigrew AG, Campbell DJ. Clinical apnea and brainstem neural function in preterm infants. N Engl J Med 1983;308:353-7.
23. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 1997;100:354-9.
24. Henderson-Smart DJ, Steer P. Methylxanthine for apnea in preterm infants (Cochrane Review). In: The Cochrane Library. Issue 4. Oxford: Update Software, 1999.
25. Blanchard PW, Aranda JV. In: Beckerman RC, Brouillette RT, Hunt CE, eds. Respiratory control disorders in infants and children. Baltimore: Williams & Wilkins, 1992.
26. Davis PG, Doyle LW, Rickards AL et al. Methylxanthines and sensorineural outcome at 14 years in children < 1501 g birthweight. J Paediatr Child Hlth 2000;36:47-50.
27. Schmidt B. Methylxanthine therapy in premature infants: sound practice, disaster or fruitless byway? J Pediatr 1999; 135:526-8.
28. Henderson-Smart DJ, Steer P. Prophylactic methylxanthine for the prevention of apnea in preterm infants (Cochrane Review). In: The Cochrane Library. Issue 1. Oxford: Update Software, 1999.
29. Henderson-Smart DJ, Steer P. Caffeine vs theophylline treatment for apnea in preterm infants (Cochrane Review). In: The Cochrane Library. Issue 2. Oxford: Update Software, 1999.
30. Hoffmann HJ, Damus K, Hillman L, Krongrad E. Risk factors for SIDS. Results of the National Institutes of Child Health and Human Development SIDS Cooperative Epidemiology Study. Ann NY Acad Sci 1988;533:13-20.
31. Jones RAK, Lukeman D. Apnea of immaturity. Arch Dis Child 1982;57:766-8.
32. Tudehope DI, Rogers YM, Burns YR, Mohay H, O'Callaghan MJ. Apnea in very low birthweight infants: Outcome at 2 years. Aust Paed J 1986;22:131-4.
33. Levitt GA, Mushin A, Bellman S, Harvey DR. Outcome of preterm infants who suffered neonatal apnoeic attacks. Early Hum Develop 1988;16:235-43.
34. Koons AH, MJoica N, Jadeja N et al. Neurodevelopmental outcome of infants with apnea of infancy. Am J Perinatol 1993;10:208-11.
35. Gunn TR, Easdown J, Outerbridge EW, Aranda JV. Risk factors in retrolental fibroplasia. Pediatrics 1980;65:1096-100.